Response Genetics, Inc (RGDXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 3:00 PM EST
Response Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2009 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '15 Mar 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2009 - 2005 |
| Revenue | 16.62 | 16.72 | 19.8 | 18.74 | 22.64 | 21.28 | Upgrade
|
| Revenue Growth (YoY) | -8.06% | -15.56% | 5.68% | -17.25% | 6.42% | 134.68% | Upgrade
|
| Cost of Revenue | 10.37 | 10.49 | 10.46 | 10.42 | 11.73 | 10.46 | Upgrade
|
| Gross Profit | 6.25 | 6.23 | 9.35 | 8.32 | 10.91 | 10.82 | Upgrade
|
| Selling, General & Admin | 18.37 | 17.99 | 15.68 | 13.85 | 15.11 | 13.71 | Upgrade
|
| Research & Development | 1.53 | 1.73 | 1.61 | 2.13 | 1.32 | 1.61 | Upgrade
|
| Operating Expenses | 19.9 | 19.72 | 17.29 | 15.98 | 16.43 | 15.33 | Upgrade
|
| Operating Income | -13.65 | -13.49 | -7.95 | -7.66 | -5.52 | -4.51 | Upgrade
|
| Interest Expense | -1.02 | -0.66 | -0.09 | -0.09 | -0.02 | -0.01 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | 0.02 | -0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | -0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -14.69 | -14.18 | -8.02 | -7.76 | -5.55 | -4.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.16 | -0.37 | Upgrade
|
| Other Unusual Items | 0.48 | 0.48 | - | - | - | 0.22 | Upgrade
|
| Pretax Income | -14.21 | -13.7 | -8.02 | -7.76 | -5.7 | -4.67 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | 0 | Upgrade
|
| Net Income | -14.21 | -13.7 | -8.02 | -7.76 | -5.7 | -4.67 | Upgrade
|
| Net Income to Common | -14.21 | -13.7 | -8.02 | -7.76 | -5.7 | -4.67 | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 33 | 27 | 19 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 33 | 27 | 19 | 18 | Upgrade
|
| Shares Change (YoY) | 10.91% | 15.75% | 25.20% | 39.83% | 7.49% | 34.01% | Upgrade
|
| EPS (Basic) | -0.37 | -0.35 | -0.24 | -0.29 | -0.30 | -0.26 | Upgrade
|
| EPS (Diluted) | -0.37 | -0.35 | -0.24 | -0.29 | -0.30 | -0.26 | Upgrade
|
| Free Cash Flow | -13.11 | -14.35 | -7.12 | -8.44 | -5.41 | -6.88 | Upgrade
|
| Free Cash Flow Per Share | -0.34 | -0.37 | -0.21 | -0.32 | -0.28 | -0.39 | Upgrade
|
| Gross Margin | 37.60% | 37.25% | 47.20% | 44.41% | 48.18% | 50.84% | Upgrade
|
| Operating Margin | -82.15% | -80.67% | -40.13% | -40.87% | -24.40% | -21.19% | Upgrade
|
| Profit Margin | -85.54% | -81.93% | -40.50% | -41.40% | -25.18% | -21.95% | Upgrade
|
| Free Cash Flow Margin | -78.89% | -85.82% | -35.94% | -45.03% | -23.89% | -32.35% | Upgrade
|
| EBITDA | -12.84 | -12.66 | -7.31 | -7.19 | -5.16 | -4.04 | Upgrade
|
| EBITDA Margin | -77.26% | -75.72% | -36.93% | -38.36% | -22.78% | -19.00% | Upgrade
|
| D&A For EBITDA | 0.81 | 0.83 | 0.63 | 0.47 | 0.37 | 0.47 | Upgrade
|
| EBIT | -13.65 | -13.49 | -7.95 | -7.66 | -5.52 | -4.51 | Upgrade
|
| EBIT Margin | -82.15% | -80.67% | -40.13% | -40.87% | -24.40% | -21.19% | Upgrade
|
| Advertising Expenses | - | 0.06 | 0.02 | 0.01 | 0.1 | 0.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.